<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35493814</PMID><DateRevised><Year>2024</Year><Month>08</Month><Day>26</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-2295</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in neurology</Title><ISOAbbreviation>Front Neurol</ISOAbbreviation></Journal><ArticleTitle>Molecular Hydrogen as a Medical Gas for the Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Possible Efficacy Based on a Literature Review.</ArticleTitle><Pagination><StartPage>841310</StartPage><MedlinePgn>841310</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">841310</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fneur.2022.841310</ELocationID><Abstract><AbstractText>Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a disorder that is characterized by fatigue that persists for more than 6 months, weakness, sleep disturbances, and cognitive dysfunction. There are multiple possible etiologies for ME/CFS, among which mitochondrial dysfunction plays a major role in abnormal energy metabolism. The potential of many substances for the treatment of ME/CFS has been examined; however, satisfactory outcomes have not yet been achieved. The development of new substances for curative, not symptomatic, treatments is desired. Molecular hydrogen (H<sub>2</sub>) ameliorates mitochondrial dysfunction by scavenging hydroxyl radicals, the most potent oxidant among reactive oxygen species. Animal experiments and clinical trials reported that H<sub>2</sub> exerted ameliorative effects on acute and chronic fatigue. Therefore, we conducted a literature review on the mechanism by which H<sub>2</sub> improves acute and chronic fatigue in animals and healthy people and showed that the attenuation of mitochondrial dysfunction by H<sub>2</sub> may be involved in the ameliorative effects. Although further clinical trials are needed to determine the efficacy and mechanism of H<sub>2</sub> gas in ME/CFS, our literature review suggested that H<sub>2</sub> gas may be an effective medical gas for the treatment of ME/CFS.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Hirano, Ichikawa, Sato, Takefuji and Satoh.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hirano</LastName><ForeName>Shin-Ichi</ForeName><Initials>SI</Initials><AffiliationInfo><Affiliation>Department of Research and Development, MiZ Company Limited, Kamakura, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ichikawa</LastName><ForeName>Yusuke</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Research and Development, MiZ Company Limited, Kamakura, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>MiZ Inc., Newark, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sato</LastName><ForeName>Bunpei</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Research and Development, MiZ Company Limited, Kamakura, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>MiZ Inc., Newark, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takefuji</LastName><ForeName>Yoshiyasu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Professor Emeritus, Keio University, Tokyo, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Data Science, Musashino University, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Satoh</LastName><ForeName>Fumitake</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Research and Development, MiZ Company Limited, Kamakura, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>MiZ Inc., Newark, CA, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Neurol</MedlineTA><NlmUniqueID>101546899</NlmUniqueID><ISSNLinking>1664-2295</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">chronic fatigue syndrome (CFS)</Keyword><Keyword MajorTopicYN="N">hydroxyl radicals</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">mitochondrial dysfunction</Keyword><Keyword MajorTopicYN="N">molecular hydrogen</Keyword><Keyword MajorTopicYN="N">myalgic encephalomyelitis (ME)</Keyword><Keyword MajorTopicYN="N">oxidative stress</Keyword><Keyword MajorTopicYN="N">post COVID</Keyword></KeywordList><CoiStatement>S-iH, YI, BS, and FS are employed by MiZ Company Limited. The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>3</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>5</Month><Day>2</Day><Hour>6</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>5</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>3</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>4</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35493814</ArticleId><ArticleId IdType="pmc">PMC9042428</ArticleId><ArticleId IdType="doi">10.3389/fneur.2022.841310</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Carruthers BM, Van de Sande MI, De Meirleir KL, Klimas NG, Broderick G, Mitchell T, et al. . Myalgic encephalomyelitis: International consensus criteria. J Intern Med. (2011) 270:327&#x2013;38. 10.1111/j.1365-2796.2011.02428.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2796.2011.02428.x</ArticleId><ArticleId IdType="pmc">PMC3427890</ArticleId><ArticleId IdType="pubmed">21777306</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuda K, Straus SE, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International chronic fatigue syndrome study group. Ann Intern Med. (1994) 121:953&#x2013;9. 10.7326/0003-4819-121-12-199412150-00009</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-121-12-199412150-00009</ArticleId><ArticleId IdType="pubmed">7978722</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff A, Takahashi R, Yamamura T, Sawamura M. Neurologic abnormalities in myalgic encephalomyelitis/chronic fatigue syndrome: A review. Brain Nerve. (2018) 70:41&#x2013;54. 10.11477/mf.1416200948</Citation><ArticleIdList><ArticleId IdType="doi">10.11477/mf.1416200948</ArticleId><ArticleId IdType="pubmed">29348374</ArticleId></ArticleIdList></Reference><Reference><Citation>Committee Committee on the diagnostic criteria for myalgic encephalomyelitis/chronic fatigue syndrome Board Board on the Health of Select Populations Institute Institute of Medicine. Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. National Academies Press.  (2015). Available online at: https://pubmed.ncbi.nlm.nih.gov/25695122/ (accessed February 18, 2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawson N, Hsieh CH, March D, Wang X. Elevated energy production in myalgic encephalomyelitis/chronic fatigue syndrome. J Nat Sci. (2016) 2:e221.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5065105</ArticleId><ArticleId IdType="pubmed">27747291</ArticleId></ArticleIdList></Reference><Reference><Citation>Boles RG, Zaki EA, Kerr JR, Das K, Biswas S, Gardner A. Increased prevalence of two mitochondrial DNA polymorphisms in function disease: are we describing different parts of an energy-deleted elephant? Mitochondrion. (2015) 23:1&#x2013;6. 10.1016/j.mito.2015.04.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mito.2015.04.005</ArticleId><ArticleId IdType="pubmed">25934187</ArticleId></ArticleIdList></Reference><Reference><Citation>Billing-Ross P, Germain A, Ye K, Keinan A, Gu Z, Hanson MR. Mitochondrial DNA variants correlate with symptoms in myalgic encephalomyelitis/chronic fatigue syndrome. J Transl Med. (2016) 14:19. 10.1186/s12967-016-0771-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-016-0771-6</ArticleId><ArticleId IdType="pmc">PMC4719218</ArticleId><ArticleId IdType="pubmed">26791940</ArticleId></ArticleIdList></Reference><Reference><Citation>Naviaux RK, Naviaux JC, Li K, Bright AT, Alaynick WA, Wang L, et al. . Metabolic features of chronic fatigue syndrome. Proc Natl Acad Sci USA. (2016) 113:E5472&#x2013;80. 10.1073/pnas.1607571113</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1607571113</ArticleId><ArticleId IdType="pmc">PMC5027464</ArticleId><ArticleId IdType="pubmed">27573827</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamano E, Sugimoto M, Hirayama A, Kume S, Yamato M, Jin G, et al. . Index markers of chronic fatigue syndrome with dysfunction of TCA and urea cycles. Sci Rep. (2016) 6:34990. 10.1038/srep34990</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep34990</ArticleId><ArticleId IdType="pmc">PMC5057083</ArticleId><ArticleId IdType="pubmed">27725700</ArticleId></ArticleIdList></Reference><Reference><Citation>Fluge &#xd8;, Mella O, Bruland O, Risa K, Dyrstad SE, Alme K, et al. . Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalomyelitis/chronic fatigue syndrome. JCL Insight. (2016) 1:e89376. 10.1172/jci.insight.89376</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.89376</ArticleId><ArticleId IdType="pmc">PMC5161229</ArticleId><ArticleId IdType="pubmed">28018972</ArticleId></ArticleIdList></Reference><Reference><Citation>Garmain A, Ruppert D, Levine SM, Hanson MR. Metabolic profiling of a myalgic encephalomyelitis/chronic fatigue syndrome discovery cohort reveals disturbances in fatty acid and lipid metabolism. Mol Biosyst. (2017) 13:371&#x2013;9. 10.1039/C6MB00600K</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C6MB00600K</ArticleId><ArticleId IdType="pmc">PMC5365380</ArticleId><ArticleId IdType="pubmed">28059425</ArticleId></ArticleIdList></Reference><Reference><Citation>Missailidis D, Annesley SJ, Allan CY, Sanislav O, Lidbury BA, Lewis DP, et al. . An isolated complex v inefficiency and dysregulated mitochondrial function in immortalized lymphocytes from ME/CFS patients. Int J Mol Sci. (2020) 21:3. 10.3390/ijms21031074</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21031074</ArticleId><ArticleId IdType="pmc">PMC7036826</ArticleId><ArticleId IdType="pubmed">32041178</ArticleId></ArticleIdList></Reference><Reference><Citation>Plioplys AV, Plioplys S. Electron-microscopic investigation of muscle mitochondria in chronic fatigue syndrome. Neuropsychobiology. (1995) 32:175&#x2013;81. 10.1159/000119233</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000119233</ArticleId><ArticleId IdType="pubmed">8587699</ArticleId></ArticleIdList></Reference><Reference><Citation>Holden S, Maksoud R, Eaton-Fitch N, Cabanas H, Staines D, Marshall-Gradisnik S. A systematic review of mitochondrial abnormalities in myalgic encephalomyelitis/chronic fatigue syndrome/systemic exertion intolerance disease. J Transl Med. (2020) 18:290. 10.1186/s12967-020-02452-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-020-02452-3</ArticleId><ArticleId IdType="pmc">PMC7392668</ArticleId><ArticleId IdType="pubmed">32727475</ArticleId></ArticleIdList></Reference><Reference><Citation>Venter M, Tomas C, Pienaar IS, Strassheim V, Erasmus E, Ng W-F, et al. . MtDNA population variation in myalgic encephalomyelitis/chronic fatigue syndrome in two populations: a study of mildly deleterious variants. Sci Rep. (2019) 9:1. 10.1038/s41598-019-39060-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-39060-1</ArticleId><ArticleId IdType="pmc">PMC6393470</ArticleId><ArticleId IdType="pubmed">30814539</ArticleId></ArticleIdList></Reference><Reference><Citation>Maes M, Mihaylova I, Kubera M, Uytterhoeven M, Vrydags N, Bosmans E. Coenzyme Q10 deficiency in myalgic encephalomyelitis / chronic fatigue syndrome (ME/CFS) is related to fatigue, autonomic and neurocognitive symptoms and is another risk factor explaining the early mortality in ME/CFS due to cardiovascular disorder. Neuroendocrinol Lett. (2009) 30:470&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">20010505</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong CW, McGregor NR, Lewis DP, Butt HL, Gooley PR. Metabolic profiling reveals anomalous energy metabolism and oxidative stress pathways in chronic fatigue syndrome patients. Metabolomics. (2015) 11:1626&#x2013;39. 10.1007/s11306-015-0816-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11306-015-0816-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Booth NE, Myhill S, McLaren-Howard J. Mitochondrial dysfunction and the pathophysiology of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Int J Clin Exp Med. (2012) 5:208&#x2212;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3403556</ArticleId><ArticleId IdType="pubmed">22837795</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomas C, Brown A, Strassheim V, Elson J, Newton J, Manning P. Cellular bioenergetics is impaired in patients with chronic fatigue syndrome. PLoS ONE. (2017) 12:e018802. 10.1371/journal.pone.0186802</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0186802</ArticleId><ArticleId IdType="pmc">PMC5655451</ArticleId><ArticleId IdType="pubmed">29065167</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen T, Staines D, Nilius B, Smith P, Marshall-Gradisnik S. Novel identification and characterisation of Transient receptor potential melastatin 3 ion channels on Natural Killer cells and B lymphocytes: Effects on cell signalling in chronic fatigue syndrome/myalgic encephalomyelitis patients. Biol Res. (2016) 49:1. 10.1186/s40659-016-0087-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40659-016-0087-2</ArticleId><ArticleId IdType="pmc">PMC4888729</ArticleId><ArticleId IdType="pubmed">27245705</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro-Marrero J, Cordero MD, S&#xe1;ez-Francas N, Jimenez-Gutierrez C, Aguilar-Montilla FJ, Aliste L, et al. . Could mitochondrial dysfunction be a differentiating marker between chronic fatigue syndrome and fibromyalgia? Antioxid Redox Signal. (2013) 19:1855&#x2013;60. 10.1089/ars.2013.5346</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2013.5346</ArticleId><ArticleId IdType="pubmed">23600892</ArticleId></ArticleIdList></Reference><Reference><Citation>Shungu DC, Weiduschat N, Murrough JW, Mao X, Pillemer S, Dyke JP, et al. . Increased ventricular lactate in chronic fatigue syndrome. III. Relationships to cortical glutathione and clinical symptoms implicate oxidative stress in disorder pathophysiology. NMR Biomed. (2012) 25:1073&#x2013;87. 10.1002/nbm.2772</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/nbm.2772</ArticleId><ArticleId IdType="pmc">PMC3896084</ArticleId><ArticleId IdType="pubmed">22281935</ArticleId></ArticleIdList></Reference><Reference><Citation>Light KC, Agarwal N, Iacob E, White AT, Kinney AY, VanHaitsma TA, et al. . Differing leukocyte gene expression profiles associated with fatigue in patients with prostate cancer versus chronic fatigue syndrome. Psychoneuroendocrinology. (2013) 38:2983&#x2013;95. 10.1016/j.psyneuen.2013.08.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psyneuen.2013.08.008</ArticleId><ArticleId IdType="pmc">PMC3848711</ArticleId><ArticleId IdType="pubmed">24054763</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen T, Staines D, Johnston S, Marshall-Gradisnik S. Reduced glycolytic reserve in isolated natural killer cells from myalgic encephalomyelitis/chronic fatigue syndrome patients: a preliminary investigation. Asian Pac J Allergy Immunol. (2019) 37:102&#x2013;8. 10.12932/AP-011117-0188</Citation><ArticleIdList><ArticleId IdType="doi">10.12932/AP-011117-0188</ArticleId><ArticleId IdType="pubmed">29981562</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweetman E, Ryan M, Edgar C, Mackay A, Vallings R, Tate W. Changes in the transcriptome of circulating immune cells of a New Zealand cohort with myalgic encephalomyelitis/chronic fatigue syndrome. Int J Immunopathol Pharmacol. (2019) 33:1. 10.1177/2058738418820402</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2058738418820402</ArticleId><ArticleId IdType="pmc">PMC6350121</ArticleId><ArticleId IdType="pubmed">30791746</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowe PC, Underhill RA, Friedman KJ, Gurwitt A, Medow MS, Schwartz MS. Myalgic encephalomyelitis/chronic fatigue syndrome diagnosis and management in young people: A primer. Front Pediatr. (2017) 5:121. 10.3389/fped.2017.00121</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2017.00121</ArticleId><ArticleId IdType="pmc">PMC5474682</ArticleId><ArticleId IdType="pubmed">28674681</ArticleId></ArticleIdList></Reference><Reference><Citation>Reeves WC, Jones JF, Maloney E, Heim C, Hoaglin DC, Boneva S, et al. . Prevalence of chronic fatigue syndrome in metropolitan, urban, and rural Georgia. Popul Health Metr. (2007) 5:1&#x2013;10. 10.1186/1478-7954-5-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1478-7954-5-5</ArticleId><ArticleId IdType="pmc">PMC1904178</ArticleId><ArticleId IdType="pubmed">17559660</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohsawa I, Ishikawa M, Takahashi K, Watanabe M, Nishimaki K. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nat Med. (2007) 13:688&#x2013;94. 10.1038/nm1577</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1577</ArticleId><ArticleId IdType="pubmed">17486089</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen JB, Kong XF, Lv YY, Qin SC, Sun XJ, Mu F, et al. . &#x201c;Real world survey&#x201d; of hydrogen-controlled cancer: a follow-up report of 82 advanced cancer patients. Med Gas Res. (2019) 9:115&#x2013;21. 10.4103/2045-9912.266985</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/2045-9912.266985</ArticleId><ArticleId IdType="pmc">PMC6779007</ArticleId><ArticleId IdType="pubmed">31552873</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen JB, Kong XF, Mu F, Lu TY, Lu YY, Xu KC. Hydrogen therapy can be used to control tumor progression and alleviate the adverse events of medications in patients with advanced non-small cell lung cancer. Med Gas Res. (2020) 10:75&#x2013;80. 10.4103/2045-9912.285560</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/2045-9912.285560</ArticleId><ArticleId IdType="pmc">PMC7885710</ArticleId><ArticleId IdType="pubmed">32541132</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirano S-I, Yamamoto H, Ichikawa Y, Sato B, Takefuji Y, Satoh F. Molecular hydrogen as a novel antitumor agent: possible mechanism underlying gene expression. Int J Mol Sci. (2021) 22:8724. 10.3390/ijms22168724</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22168724</ArticleId><ArticleId IdType="pmc">PMC8395776</ArticleId><ArticleId IdType="pubmed">34445428</ArticleId></ArticleIdList></Reference><Reference><Citation>Akagi J, Baba H. Hydrogen gas restores exhausted CD8+ T cells in patients with advanced colorectal cancer to improve prognosis. Oncol Rep. (2018) 41:301&#x2013;11. 10.3892/or.2018.6841</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/or.2018.6841</ArticleId><ArticleId IdType="pubmed">30542740</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsumata Y, Sano F, Abe T, Tamura T, Fujisawa T. The effects of hydrogen gas inhalation on adverse left ventricular remodeling after percutaneous coronary intervention for ST-elevated myocardial infraction. First pilot study in humans. Circ J. (2017) 81:940&#x2013;7. 10.1253/circj.CJ-17-0105</Citation><ArticleIdList><ArticleId IdType="doi">10.1253/circj.CJ-17-0105</ArticleId><ArticleId IdType="pubmed">28321000</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamura T, Hayashida K, Sano M, Suzuki M, Shibusawa T, Yoshizawa J, et al. . Feasibility and safety of hydrogen gas inhalation for post-cardiac arrest syndrome. Circ J. (2016) 80:1870&#x2013;3. 10.1253/circj.CJ-16-0127</Citation><ArticleIdList><ArticleId IdType="doi">10.1253/circj.CJ-16-0127</ArticleId><ArticleId IdType="pubmed">27334126</ArticleId></ArticleIdList></Reference><Reference><Citation>Ono H, Nishijima Y, Adachi N, Tachibana S, Chitoku S, Mukaihara S, et al. . Improved brain MRI indices in the acute brain stem infarct sites treated with hydroxyl radical scavengers, Edaravone and hydrogen, as compared to Edaravone alone. A non-controlled study. Med. Gas Res. (2011) 1:12. 10.1186/2045-9912-1-12</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2045-9912-1-12</ArticleId><ArticleId IdType="pmc">PMC3231971</ArticleId><ArticleId IdType="pubmed">22146068</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoritaka A, Takanashi M, Hirayama M, Nakahara T, Ohta S, Hattori N. Pilot study of H2 therapy in Parkinson's disease. A randomized double-blind placebo-controlled trial. Mov Disord. (2013) 28:836&#x2013;9. 10.1002/mds.25375</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.25375</ArticleId><ArticleId IdType="pubmed">23400965</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan WJ, Wei CH, Chen AL, Sun XC, Guo GY, Zou X, et al. . Hydrogen/oxygen mixed gas inhalation improves disease severity and dyspnea in patients with Coronavirus disease 2019 in a recent multicenter, open-label clinical trial. J Thorac Dis. (2020) 12:3448&#x2013;52. 10.21037/jtd-2020-057</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/jtd-2020-057</ArticleId><ArticleId IdType="pmc">PMC7330772</ArticleId><ArticleId IdType="pubmed">32642277</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong Z, Guan J, Ren X, Meng D, Zhang H, Wang B, et al. . Protective effect of hydrogen on the lung of sanitation workers exposed to haze. Chin J Tuberc Respir Dis. (2016) 39:916&#x2013;23. 10.3760/cma.j.issn.1001-0939.2016.12.003</Citation><ArticleIdList><ArticleId IdType="doi">10.3760/cma.j.issn.1001-0939.2016.12.003</ArticleId><ArticleId IdType="pubmed">27938540</ArticleId></ArticleIdList></Reference><Reference><Citation>Kajiyama S, Hasegawa G, Asano M, Hosoda H, Fukui M, Nakamura N, et al. . Supplementation of hydrogen-rich water improves lipid and glucose metabolism in patients with type 2 diabetes or impaired glucose tolerance. Nutri Res. (2008) 28:137&#x2013;43. 10.1016/j.nutres.2008.01.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nutres.2008.01.008</ArticleId><ArticleId IdType="pubmed">19083400</ArticleId></ArticleIdList></Reference><Reference><Citation>Song G, Li M, Sang H, Zhang L, Li X. Hydrogen-rich water decreases serum low-density lipoprotein cholesterol levels and improves high-density lipoprotein function in patients with potential metabolic syndrome. J Lipid Res. (2013) 54:1884&#x2013;93. 10.1194/jlr.M036640</Citation><ArticleIdList><ArticleId IdType="doi">10.1194/jlr.M036640</ArticleId><ArticleId IdType="pmc">PMC3679390</ArticleId><ArticleId IdType="pubmed">23610159</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohta S. Molecular hydrogen as a preventive and therapeutic medical gas: initiation, development and potential of hydrogen medicine. Pharmacol Ther. (2014) 144:1&#x2013;11. 10.1016/j.pharmthera.2014.04.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2014.04.006</ArticleId><ArticleId IdType="pubmed">24769081</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohta S. Molecular hydrogen as a novel antioxidant: overview of the advantages of hydrogen for medical applications. Methods Enzymol. (2015) 555:289&#x2013;317. 10.1016/bs.mie.2014.11.038</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.mie.2014.11.038</ArticleId><ArticleId IdType="pubmed">25747486</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirano S-i, Ichikawa Y, Kurokawa R, Takefuji Y, Satoh F. A &#x201c;philosophical molecule,&#x201d; hydrogen may overcome senescence and intractable diseases. Med Gas Res. (2020) 10:47&#x2013;9. 10.4103/2045-9912.279983</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/2045-9912.279983</ArticleId><ArticleId IdType="pmc">PMC7871941</ArticleId><ArticleId IdType="pubmed">32189669</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirano S-i, Ichikawa Y, Sato B, Yamamoto H, Takefuji Y, Satoh F. Potential therapeutic applications of hydrogen in chronic inflammatory disease: possible inhibiting role on mitochondrial stress. Int J Mol Sci. (2021) 22:2549. 10.3390/ijms22052549</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22052549</ArticleId><ArticleId IdType="pmc">PMC7961517</ArticleId><ArticleId IdType="pubmed">33806292</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto H, Ichikawa Y, Hirano S-i, Sato B, Takefuji Y, Satoh F. Molecular hydrogen as a novel protective agent against pre-symptomatic diseases. Int J Mol Sci. (2021) 22:7211. 10.3390/ijms22137211</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22137211</ArticleId><ArticleId IdType="pmc">PMC8268741</ArticleId><ArticleId IdType="pubmed">34281264</ArticleId></ArticleIdList></Reference><Reference><Citation>Ara J, Fadriquela A, Ahmed MF, Bajgai J, Sajo MEJ, Lee SP, et al. . Hydrogen water drinking exerts antifatigue effects and in chronic forced swimming via antioxidative and anti-inflammatory activities. Biomed Res Int. (2018) 2018:2571269. 10.1155/2018/2571269</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/2571269</ArticleId><ArticleId IdType="pmc">PMC5932502</ArticleId><ArticleId IdType="pubmed">29850492</ArticleId></ArticleIdList></Reference><Reference><Citation>Nogueira JE, Passaglia P, Mota CMD, Santos BM, Batalh&#xe3;o ME, et al. . Molecular hydrogen reduces acute exercise-induced inflammatory and oxidative stress status. Free Radic Biol Med. (2018) 129:186&#x2013;93. 10.1016/j.freeradbiomed.2018.09.028</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2018.09.028</ArticleId><ArticleId IdType="pubmed">30243702</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamazaki M, Kusano K, Ishibashi T, Kikuchi M, Koyama K. Intravenous infusion of H2-saline suppresses oxidative stress and elevates antioxidant potential in Thoroughbred horses after racing exercise. Sci Rep. (2015) 5:15514. 10.1038/srep15514</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep15514</ArticleId><ArticleId IdType="pmc">PMC4616033</ArticleId><ArticleId IdType="pubmed">26493164</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsubone H, Hanafusa M, Endo M, Manabe N, Hiraga A, et al. . Effect of treadmill exercise and hydrogen-rich water intake on serum oxidative metabolites in serum of Thoroughbred horses. J Equine Sci. (2013) 24:1&#x2013;8. 10.1294/jes.24.1</Citation><ArticleIdList><ArticleId IdType="doi">10.1294/jes.24.1</ArticleId><ArticleId IdType="pmc">PMC4013981</ArticleId><ArticleId IdType="pubmed">24833996</ArticleId></ArticleIdList></Reference><Reference><Citation>Aoki K, Nakao A, Adachi T, Matsui Y, Miyakawa S. Pilot study: Effects of drinking hydrogen-rich water on muscle fatigue caused by acute exercise in elite athletes. Med Gas Res. (2012) 2:12. 10.1186/2045-9912-2-12</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2045-9912-2-12</ArticleId><ArticleId IdType="pmc">PMC3395574</ArticleId><ArticleId IdType="pubmed">22520831</ArticleId></ArticleIdList></Reference><Reference><Citation>Mikami T, Tano K, Lee H, Park J, Ohta F, LeBaron TW, et al. . Drinking hydrogen water enhances endurance and relieves psychometric fatigue: a randomized, double-blind, placebo-controlled study. Can J Physiol Pharmacol. (2019) 97:857&#x2013;62. 10.1139/cjpp-2019-0059</Citation><ArticleIdList><ArticleId IdType="doi">10.1139/cjpp-2019-0059</ArticleId><ArticleId IdType="pubmed">31251888</ArticleId></ArticleIdList></Reference><Reference><Citation>Botek M, Krej&#x10d;&#xed; J, McKune AJ, Sl&#xe1;de&#x10d;kov&#xe1; B, Naumovski N. Hydrogen rich water improved ventilatory, perceptual and lactate responses to exercise. Int J Sports Med. (2019) 40:879&#x2013;85. 10.1055/a-0991-0268</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-0991-0268</ArticleId><ArticleId IdType="pubmed">31574544</ArticleId></ArticleIdList></Reference><Reference><Citation>Shibayama Y, Dobashi S, Arisawa T, Fukuoka T, Koyama K. Impact of hydrogen-rich gas mixture inhalation through nasal cannula during post-exercise recovery period on subsequent oxidative stress, muscle damage, and exercise performances in men. Med Gas Res. (2020) 10:155&#x2013;62. 10.4103/2045-9912.304222</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/2045-9912.304222</ArticleId><ArticleId IdType="pmc">PMC8092152</ArticleId><ArticleId IdType="pubmed">33380581</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobashi S, Takeuchi K, Koyama K. Hydrogen-rich water suppresses the reduction in blood total antioxidant capacity induced by 3 consecutive days of severe exercise in physically active males. Med Gas Res. (2020) 10:21&#x2013;6. 10.4103/2045-9912.279979</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/2045-9912.279979</ArticleId><ArticleId IdType="pmc">PMC7871940</ArticleId><ArticleId IdType="pubmed">32189665</ArticleId></ArticleIdList></Reference><Reference><Citation>Hori A, Sobue S, Kurokawa R, Hirano S-i, Ichihara M, Hotta N. Two-week continuous supplementation of hydrogen-rich water increases peak oxygen uptake during an incremental cycling exercise test in healthy humans: a randomized, single-blinded, placebo-controlled study. Med Gas Res. (2020) 10:163&#x2013;9. 10.4103/2045-9912.304223</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/2045-9912.304223</ArticleId><ArticleId IdType="pmc">PMC8092150</ArticleId><ArticleId IdType="pubmed">33380582</ArticleId></ArticleIdList></Reference><Reference><Citation>Tim&#xf3;n R, Olcina G, Gonzalez-Custodio A, Camecho-Cardenosa M, Camacho-Cardenosa A, Guardado IM. Effects of 7-day intake of hydrogen-rich water on physical performance of trained and untrained subjects. Biol Sport. (2021) 38:269&#x2013;75. 10.5114/biolsport.2020.98625</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/biolsport.2020.98625</ArticleId><ArticleId IdType="pmc">PMC8139351</ArticleId><ArticleId IdType="pubmed">34079172</ArticleId></ArticleIdList></Reference><Reference><Citation>Da Ponte A, Giovanelli N, Nigris D, Lazzer S. Effects of hydrogen rich water on prolonged intermittent exercise. J Sports Med Phys Fitness. (2018) 58:612&#x2013;21. 10.23736/S0022-4707.17.06883-9</Citation><ArticleIdList><ArticleId IdType="doi">10.23736/S0022-4707.17.06883-9</ArticleId><ArticleId IdType="pubmed">28474871</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris G, Puri BK, Walker A, Maes M, Carvalho AF, Walder K, et al. . Myalgic encephalomyelitis/chronic fatigue syndrome: pathophysiological insights to novel therapeutic opportunities. Pharmacol Res. (2019) 48:104450. 10.1016/j.phrs.2019.104450</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2019.104450</ArticleId><ArticleId IdType="pubmed">31509764</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas K, Rosch M, Langguth P. Molecular hydrogen (H2) as a potential treatment for acute and chronic fatigue. Arch Phram. (2021) 354:e2000378. 10.1002/ardp.202000378</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ardp.202000378</ArticleId><ArticleId IdType="pubmed">33368699</ArticleId></ArticleIdList></Reference><Reference><Citation>Carruthers B, Jain AK, De Meirleir KL, Peterson DL, Klimas NG, Lerner AM, et al. . Myalgic encephalomyelitis/chronic fatigue syndrome. J Chron Fatigue Syndr. (2003) 11:7&#x2013;115. 10.1300/J092v11n01_02</Citation><ArticleIdList><ArticleId IdType="doi">10.1300/J092v11n01_02</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason LA, McManimen S, Sunnquis M, Brown A, Newton JL, Strand EB. Examining the Institute of Medicine's Recommendations regarding chronic fatigue syndrome: Clinical versus research criteria. J Neurol Phychol. (2015) 2015 (Suppl 2) Available online at: http://www.avensonline.org/wp-content/uploads/JNP-2332-3469-S2-0002.pdf</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5008852</ArticleId><ArticleId IdType="pubmed">27595126</ArticleId></ArticleIdList></Reference><Reference><Citation>Hornig M, Montoya JG, Klimas NG, Levine S, Felsenstein D, Bateman L, et al. . Distinct plasma immune signature in ME/CFS are present early in the course of illness. Sci Adv. (2015) 1:e1400121. 10.1126/sciadv.1400121</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.1400121</ArticleId><ArticleId IdType="pmc">PMC4465185</ArticleId><ArticleId IdType="pubmed">26079000</ArticleId></ArticleIdList></Reference><Reference><Citation>Hornig M, Gottschalk G, Peterson DL, Knox KK, Schultz AF, Eddy ML, et al. . Cytokine network analysis of cerebrospinal fluid in myalgic encephalomyelitis/chronic fatigue syndrome. Mol Phychiatry. (2016) 21:261&#x2013;9. 10.1038/mp.2015.29</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mp.2015.29</ArticleId><ArticleId IdType="pubmed">25824300</ArticleId></ArticleIdList></Reference><Reference><Citation>Poenaru S, Abdallah SJ, Corrales-Medina V, Cowan J. COVID-19 and post-infectious myalgic encephalomyelitis/chronic fatigue syndrome: a narrative review. Ther Adv Infectious Dis. (2021) 8:1&#x2013;16. 10.1177/20499361211009385</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20499361211009385</ArticleId><ArticleId IdType="pmc">PMC8060761</ArticleId><ArticleId IdType="pubmed">33959278</ArticleId></ArticleIdList></Reference><Reference><Citation>Nath A. Long-haul COVID. Neurology. (2020) 95:559&#x2013;60. 10.1212/WNL.0000000000010640</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000010640</ArticleId><ArticleId IdType="pubmed">32788251</ArticleId></ArticleIdList></Reference><Reference><Citation>Fluge &#xd8;, Rekeland IG, Lien K, Th&#xfc;rmer H, Borchgrevink PC, Sch&#xe4;fer C, et al. . B-lymphocyte depletion in patients with myalgic encephalomyelitis/chronic fatigue syndrome: A randomized, double-blind, placebo-controlled trial. Ann Intern Med. (2019) 170:585&#x2013;93. 10.7326/M18-1451</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M18-1451</ArticleId><ArticleId IdType="pubmed">30934066</ArticleId></ArticleIdList></Reference><Reference><Citation>Missailidis D, Annesley SJ, Fisher PR. Pathological mechanisms underlying myalgic encephalomyelitis/chronic fatigue syndrome. Diagnostics. (2019) 9:3. 10.3390/diagnostics9030080</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics9030080</ArticleId><ArticleId IdType="pmc">PMC6787592</ArticleId><ArticleId IdType="pubmed">31330791</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro-Marrero J, S&#xe1;ez-Franc&#xe0;s N, Segundo MJ, Calvo N, Faro M, Aliste L., et al. . Effect of coenzyme Q10 plus nicotinamide adenine dinucleotide supplementation on maximum heart rate after exercise testing in chronic fatigue syndrome - A randomized, controlled, double-blind trial. Clin Nutr. (2016) 35:826&#x2013;34. 10.1016/j.clnu.2015.07.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnu.2015.07.010</ArticleId><ArticleId IdType="pubmed">26212172</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro-Marrero J, Cordero MD, Segundo MJ, S&#xe1;ez-Franc&#xe0;s N, Calvo N, Rom&#xe1;n-Malo L, et al. . Does oral coenzyme Q10 plus NADH supplementation improve fatigue and biochemical parameters in chronic fatigue syndrome? Antioxid Redox Signal. (2015) 22:679&#x2013;85. 10.1089/ars.2014.6181</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2014.6181</ArticleId><ArticleId IdType="pmc">PMC4346380</ArticleId><ArticleId IdType="pubmed">25386668</ArticleId></ArticleIdList></Reference><Reference><Citation>Forsyth LM, Preuss HG, MacDowell AL, Chiazze L, Birkmayer GD, Bellanti JA. Therapeutic effects of oral NADH on the symptoms of patients with chronic fatigue syndrome. Ann Allergy Asthma Immunol. (1999) 82:185&#x2013;91. 10.1016/S1081-1206(10)62595-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1081-1206(10)62595-1</ArticleId><ArticleId IdType="pubmed">10071523</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirano S-i, Ichikawa Y, Sato B, Yamamoto H, Takefuji Y, Satoh F. Molecular hydrogen as a potential clinically applicable radioprotective agent. Int J Mol Sci. (2021) 22:4566. 10.3390/ijms22094566</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22094566</ArticleId><ArticleId IdType="pmc">PMC8123813</ArticleId><ArticleId IdType="pubmed">33925430</ArticleId></ArticleIdList></Reference><Reference><Citation>Tschopp J. Mitochondria: Sovereign of inflammation? Eur J Immunol. (2011) 41:1196&#x2013;202. 10.1002/eji.201141436</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201141436</ArticleId><ArticleId IdType="pubmed">21469137</ArticleId></ArticleIdList></Reference><Reference><Citation>Ismael S, Ahmed HA, Adris T, Parveen K, Thakor P, Ishrat T. The NLRP3 inflammasome: a potent therapeutic target for traumatic brain injury. Neural Regen Res. (2020) 16:49&#x2013;57. 10.4103/1673-5374.286951</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.286951</ArticleId><ArticleId IdType="pmc">PMC7818859</ArticleId><ArticleId IdType="pubmed">32788447</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosseinian N, Cho Y, Lockey RF, Kolliputi N. The role of the NLRP3 inflammasome in pulmonary diseases. Ther Adv Respir Dis. (2015) 9:188&#x2013;97. 10.1177/1753465815586335</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1753465815586335</ArticleId><ArticleId IdType="pubmed">26012351</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozaki E, Campbell M, Doyle SL. Targeting the NLRP3 inflammasome in chronic inflammatory diseases: current perspectives. J Inflamm Res. (2015) 8:15&#x2013;27. 10.2147/JIR.S51250</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JIR.S51250</ArticleId><ArticleId IdType="pmc">PMC4303395</ArticleId><ArticleId IdType="pubmed">25653548</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimada K, Crother TR, Karlin J, Dagvadorj J, Chiba N, Chen S, et al. . Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity. (2012) 36:401&#x2013;14. 10.1016/j.immuni.2012.01.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2012.01.009</ArticleId><ArticleId IdType="pmc">PMC3312986</ArticleId><ArticleId IdType="pubmed">22342844</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong Z, Liang S, Sanchez-Lopez E, He F, Shalapour S, Lin XJ, et al. . New mitochondrial DNA synthesis enables NLRP3 inflammasome activation. Nature. (2018) 560:198&#x2013;203. 10.1038/s41586-018-0372-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0372-z</ArticleId><ArticleId IdType="pmc">PMC6329306</ArticleId><ArticleId IdType="pubmed">30046112</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallet SM, Puri V, Gibson FC. Linkage of infection to adverse systemic complication: periodontal disease, toll-like receptors, and other pattern recognition systems. Vaccines (Basel). (2018) 6:21. 10.3390/vaccines6020021</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines6020021</ArticleId><ArticleId IdType="pmc">PMC6027258</ArticleId><ArticleId IdType="pubmed">29621153</ArticleId></ArticleIdList></Reference><Reference><Citation>Falster C, Korfitzen S, Herold M, Lindebjerg J, Els&#xf8;e M. Discussion: Drinking hydrogen water enhances and relieves phychometric fatigue: a randomized, double-blind, placebo-controlled study. Can J Physiol Pharmacol. (2021) 99:1114&#x2013;5. 10.1139/cjpp-2021-0031</Citation><ArticleIdList><ArticleId IdType="doi">10.1139/cjpp-2021-0031</ArticleId><ArticleId IdType="pubmed">34585956</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohta S, LeBaron TW. Reply to &#x201c;Drinking hydrogen water enhances and relieves phychometric fatigue: a randomized, double-blind, placebo-controlled study&#x201d;. Can J physiol pharmacol. (2021) 99:1116&#x2013;17. 10.1139/cjpp-2021-0151</Citation><ArticleIdList><ArticleId IdType="doi">10.1139/cjpp-2021-0151</ArticleId><ArticleId IdType="pubmed">34585957</ArticleId></ArticleIdList></Reference><Reference><Citation>Sobue S, Inoue C, Hori F, Qiao S, Murate T. Molecular hydrogen modulates gene expression via histone modification and induces the mitochondrial unfolded protein response. Biochem Biophys Res Commun. (2017) 493:318&#x2013;24. 10.1016/j.bbrc.2017.09.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2017.09.024</ArticleId><ArticleId IdType="pubmed">28890349</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizuno K, Sasaki AK, Ebisu K, Tajima K, Kajimoto O, Nojima J, et al. . Hydrogen rich water for improvements of mood, anxiety, and autonomic nerve function in daily life. Med Gas Res. (2017) 7:247&#x2013;55. 10.4103/2045-9912.222448</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/2045-9912.222448</ArticleId><ArticleId IdType="pmc">PMC5806445</ArticleId><ArticleId IdType="pubmed">29497485</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu D, Li D, Shigeta M, Ochi Y, Okauchi T, Neyama H, et al. . Alleviation of the chronic stress response attributed to the antioxidant and anti-inflammatory effects of electolyzed hydrogen water. Biochem Biophys Res Commun. (2021) 535:1&#x2013;5. 10.1016/j.bbrc.2020.12.035</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2020.12.035</ArticleId><ArticleId IdType="pubmed">33340760</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathew SJ, Mao X, Keegan KA, Levine SM, Smith ELP, Heier LA, et al. . Ventricular cerebrospinal fluid lactate is increased in chronic fatigue syndrome compared with generalized anxiety disorder: an in vivo 3.0 T 1H MRS imaging study. NMR Biomed. (2009) 22:251&#x2013;8. 10.1002/nbm.1315</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/nbm.1315</ArticleId><ArticleId IdType="pubmed">18942064</ArticleId></ArticleIdList></Reference><Reference><Citation>Mikirova N, Casciari J, Hunninghake R. The assessment of energy metabolism in patients with chronic fatigue syndrome by serum fluorescence emission. Altern Ther Health Med. (2012) 18:36&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">22516851</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandarano AH, Maya J, Giloteaux L, Peterson D, Maynard M, Gottschalk CG, et al. . Myalgic encephalomyelitis/chronic fatigue syndrome patients exhibit altered T cell metabolism and cytokine associations. J Clin Invest. (2020) 130:1491&#x2013;505. 10.1172/JCI132185</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI132185</ArticleId><ArticleId IdType="pmc">PMC7269566</ArticleId><ArticleId IdType="pubmed">31830003</ArticleId></ArticleIdList></Reference><Reference><Citation>Hornig M. Can the light of immunometabolism cut through &#x201c;brain fog&#x201d;? J Clin Invest. (2020) 130:1102&#x2013;5. 10.1172/JCI134985</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI134985</ArticleId><ArticleId IdType="pmc">PMC7269580</ArticleId><ArticleId IdType="pubmed">32039912</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuratsune H. Diagnosis and treatment of myalgic encephalomyelitis/chronic fatigue syndrome. Bain Nerve. (2018) 70:11&#x2013;8. 10.11477/mf.1416200944</Citation><ArticleIdList><ArticleId IdType="doi">10.11477/mf.1416200944</ArticleId><ArticleId IdType="pubmed">29348370</ArticleId></ArticleIdList></Reference><Reference><Citation>Ichikawa Y, Yamamoto H, Hirano S-i, Sato B, Takefuji Y, Satoh F. The overlooked benefits of hydrogen-producing bacteria. Med Gas Res. (2022) 11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9979208</ArticleId><ArticleId IdType="pubmed">36571374</ArticleId></ArticleIdList></Reference><Reference><Citation>Fontanari P, Baldier M, Guillot C, Tomei C, Barnet H, Gardette B, et al. . Changes in maximal performance of inspiratory and skeletal muscles during and after the 7.1-MPa Hydra 10 record human dive. Eur J Appl Physiol. (2000) 81:325&#x2013;8. 10.1007/s004210050050</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004210050050</ArticleId><ArticleId IdType="pubmed">10664092</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C, Kurokawa R, Fujino M, Hirano Si, Sato B, Li XK. Estimation of the hydrogen concentration in rat tissue using an airtight tube following the administration of hydrogen via various routes. Sci Rep. (2014) 4:5485. 10.1038/srep05485</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep05485</ArticleId><ArticleId IdType="pmc">PMC4074787</ArticleId><ArticleId IdType="pubmed">24975958</ArticleId></ArticleIdList></Reference><Reference><Citation>Botek M, Kre&#x1f0;c&#xed; J, Valenta M, McKune A, Sl&#xe1;d&#x11b;ckov&#xe1; B, Kon&#x11b;cn&#xfd; P, et al. . Molecular hydrogen positively affects physical and respiratory function in acute post-COVID-19 patients: A new perspective in rehabilitation. Int J Environ Res Public Health. (2022) 19:1992. 10.3390/ijerph19041992</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19041992</ArticleId><ArticleId IdType="pmc">PMC8872486</ArticleId><ArticleId IdType="pubmed">35206179</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>